5326612025-01-012025-03-315326612025-03-315326612024-03-315326612024-04-012025-03-315326612025-01-012025-03-31in-capmkt:OtherExpenses1Member5326612024-04-012025-03-31in-capmkt:OtherExpenses1Member5326612025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326612024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326612025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15326612024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15326612025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532661RMLNOTLISTEDINE050H01012RANE (MADRAS) LIMITEDMain BoardEquity2024-04-012025-03-312025-05-272025-03-30INRCroresQuarterlyFourth quarterSingle segmentThe Company operates only in one segment namely manufacture and marketing of components and providing technological services for Transportation industry2025-05-2712:45:002025-05-2713:33:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated90134000003970000090531000004641600000359600000203700000119200000018490000035530000018284000008765500000287600000-118100000169500000-735000001778000001043000000652000000000652000002500000090200000162700000102.372.37002.372.37The above FR have been reviewed by the AC and approved by the BoD at meetings held on 27.05.2025. The Co has primarily incurred merger related exp (including stamp duty chgs),one-time warranty costs and exp towards VRS amt to Rs.11.81cr forQE Mar31,2025,Rs.0.93cr in theQE Dec31,2024,Rs.7.02cr in theQE Mar31,2024,Rs.12.99cr for YE Mar 31,2025 and Rs.26.99cr for the YE Mar31,2024 as exceptional items.Pursuant to the approval of the BoD and Sh.holdrs of the Co,RMIH B.V.(the Co’s SDS)had sold its entire stake in LMCA(RML'serstwhile SDS) on sep 14,2023 for USD 4.9mn.For the YE Mar31,2024,the Co had recorded a FV loss aggregating to Rs.121.56cr in the SFR and loss on sale of SDS aggregating to Rs.85.46cr in the CFR as an exceptional item. Consequent to the sale of LMCA, RMIH B.V.had carried out a reduction of capital in the NCRPS issued to the Co. The Co had determined that it is eligible to claim the tax benefit arising from such losses and had accordingly recorded a deferred tax asset of Rs.113.34cr for the YE Mar31,2024.Consequent to sale of LMCA,the Grp has consolidated the financial performance of LMCA till Sep14,2023 and its the assets/liabilities were de-recognized in the consolidated BS on Sep14,2023.The BoD of the Co meeting on Feb29,2024,approved the amalgamation of the fellow subsidiaries of the Co viz. RBL&REVL with the co wef Apr1,2024under Sec230-232 of the CA,2013.The aforesaid Scheme was sanctioned by NCLT vide order dated Mar24, 2025 and effective from Apr01,2024.The amalgamation has been accounted in accordance with “Pooling of interest method” as laid down in App C - ‘Business combinations of entities under common control’ of IndAS103 notified under sec133 of the CA read with the Co (IAS)Rules,2015.Accordingly,comparativeshave been restated to give effect of the amalgamation from the beginning of the PY. The diff between the assets, liabilities, acquired reserves and shares transferred were transferred to CR amounting to Rs.3.59cr.During the YE Mar31,2024,the Co had set up a new subsidiary RACM S.deR.L.deC.V.and iscurrently in process of setting up the mfrg facility. Accordingly the CFR include the financial performance of this subsidiary effective from the YE Mar31,2024.During the year ended Mar31,2025,has elected to opt for the new tax regime under the IT Act,1961 wefFY 2023-24 resulting in an add.tax exp of Rs.14.20cr(including INR5.93 crores on account of reversal of MATcredit) for the current year dueremeasurement of the deferred tax asset (net).The BoD of the Co in its meeting held on May 27,2025, hasrecommended a dividend of Rs.8 per eq share of Rs.10/-each(i.e.80 %of face value)for theFYended Mar31,2025,subject to the approval of sh.holdrs in the ensuing AGM.The figures for the QE Mar31,2025 and Mar31,2024 as reported in these FR arethebalancing figures between audited figures in respect of the full FY and the published unaudited year to date figures up to the end of the third qtr of the relevant FY.2024-04-012025-03-31AuditedConsolidated340575000001567000003421420000019408000000442100000-22520000047039000007454000001323200000690790000033305300000908900000-1299000007790000000402500000402500000037650000000003765000002210000039860000016270000010654620000013.6213.620013.6213.62Other Expenses1828400000Other Expenses690790000063509000007267000000463000005359000006690000001913000002582000009948000008853000009798100000433820000007090700000337800000101000008200000318000000776480000079010000012893100000226912000001627000006546200000670890000067089000002173000000463300000263630000019970000005150000028875000005436300000166300000481820000049845000001463300000118841000008484000003623000000130948000001598230000022691200000745400000-124500000-11848000000-6680000000-1376000000672200000036570000001323200000203900000132900000-51700000053120000020400000058700000000-24200000240000014600000023636000003142600000000-14900000031575000000-406000000000002775000001845500000000000000000000000649000000-4900000-146740000000000000697180000076819000004370000026810000073990000000-1761800000-717000000-71700000296900000225200000Remeasurement gains/(losses) on defined benefit plans, net4370000043700000Remeasurement gains/(losses) on defined benefit plans, net3540000035400000112000009100000Exchange differences on translating financial statements of foreign operations-7500000-7500000Exchange differences on translating financial statements of foreign operations-4200000-4200000002500000022100000AuditedtrueB S R & Co., LLPtrue2025-07-31